MammaPrint genetic test can reduce use of post-surgery chemotherapy among early-stage
Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological criteria, the MammaPrint genetic test identified a large group...
Threaded Mode